BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 118040
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118040
Figure 2
Figure 2 Receiver operating characteristic curves of inflammatory markers for predicting minimal hepatic encephalopathy. A: Tumor necrosis factor-alpha [area under the receiver operating characteristic (AUROC): 0.934], interleukin-6 (IL-6) (AUROC: 0.864), IL-18 (AUROC: 0.962), endotoxin (AUROC: 0.976), IL-10 (AUROC: 0.976), IL-12 (AUROC: 0.984), IL-1β (AUROC: 0.993); B: Grade 1 hepatic encephalopathy [tumor necrosis factor-alpha (AUROC: 0.729)], IL-6 (AUROC: 0.751), IL-18 (AUROC: 0.812), endotoxin (AUROC: 0.989), IL-10 (AUROC: 0.833), IL-12 (AUROC: 0.921), IL-1β (AUROC: 0.938). TNF-α: Tumor necrosis factor-alpha; IL: Interleukin.


Write to the Help Desk